DZ3370A1 - Composes de piperazine et piperidine - Google Patents

Composes de piperazine et piperidine

Info

Publication number
DZ3370A1
DZ3370A1 DZ013370A DZ013370A DZ3370A1 DZ 3370 A1 DZ3370 A1 DZ 3370A1 DZ 013370 A DZ013370 A DZ 013370A DZ 013370 A DZ013370 A DZ 013370A DZ 3370 A1 DZ3370 A1 DZ 3370A1
Authority
DZ
Algeria
Prior art keywords
piperazine
piperidine compounds
piperidine
compounds
Prior art date
Application number
DZ013370A
Other languages
English (en)
Inventor
Roelof W Feenstra
Der Heijden Johannes A M Van
Cornelis G Kruse
Stephen K Long
Scharrenburg Gustaaf J M Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of DZ3370A1 publication Critical patent/DZ3370A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DZ013370A 2000-05-12 2001-05-10 Composes de piperazine et piperidine DZ3370A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201699 2000-05-12
PCT/EP2001/005320 WO2001085725A1 (fr) 2000-05-12 2001-05-10 Composes de piperazine et piperidine

Publications (1)

Publication Number Publication Date
DZ3370A1 true DZ3370A1 (fr) 2001-11-15

Family

ID=8171488

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013370A DZ3370A1 (fr) 2000-05-12 2001-05-10 Composes de piperazine et piperidine

Country Status (27)

Country Link
US (2) US6911448B2 (fr)
EP (1) EP1283838B1 (fr)
JP (1) JP2003532729A (fr)
CN (1) CN1174979C (fr)
AR (1) AR028443A1 (fr)
AT (1) ATE255578T1 (fr)
AU (2) AU2001263927B2 (fr)
BR (1) BR0110592A (fr)
CA (1) CA2405971C (fr)
CZ (1) CZ301464B6 (fr)
DE (1) DE60101386T2 (fr)
DK (1) DK1283838T3 (fr)
DZ (1) DZ3370A1 (fr)
ES (1) ES2211809T3 (fr)
HU (1) HUP0302016A2 (fr)
IL (2) IL152177A0 (fr)
MX (1) MXPA02011084A (fr)
NO (1) NO323778B1 (fr)
NZ (1) NZ522116A (fr)
PL (1) PL198857B1 (fr)
PT (1) PT1283838E (fr)
RU (1) RU2261250C2 (fr)
SK (1) SK286778B6 (fr)
TR (1) TR200302294T4 (fr)
UA (1) UA72337C2 (fr)
WO (1) WO2001085725A1 (fr)
ZA (1) ZA200208537B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283838B1 (fr) * 2000-05-12 2003-12-03 Solvay Pharmaceuticals B.V. Composes de piperazine et piperidine
ES2323451T7 (es) 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
WO2004000837A1 (fr) * 2002-06-25 2003-12-31 Sumitomo Pharmaceuticals Co., Ltd. Nouveau derive de benzoxazolinone
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (fr) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Administration iontophoretique de composés piperazinyl-2(3h)-benzoxazoloniques
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
ATE417834T1 (de) * 2005-08-22 2009-01-15 Solvay Pharm Bv N-oxide als prodrugs von piperazin- und piperidinderivaten
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
DE602007006990D1 (de) 2006-12-07 2010-07-15 Hoffmann La Roche Spiropiperidinderivate als antagonisten des via-rezeptors
DE602007006989D1 (en) 2006-12-07 2010-07-15 Hoffmann La Roche Spiropiperidinderivate
KR101050558B1 (ko) 2006-12-08 2011-07-19 에프. 호프만-라 로슈 아게 V1a 수용체 길항제로서 작용하는 인돌
ATE527249T1 (de) 2006-12-08 2011-10-15 Hoffmann La Roche Indole
BRPI0721138A2 (pt) 2006-12-22 2014-04-01 Hoffmann La Roche Derivados de espiro-piperidina
MX2010007703A (es) * 2008-01-15 2010-09-14 Abbott Healthcare Products Bv Derivados de bifeprunox.
US11103499B2 (en) 2016-08-26 2021-08-31 EXCIVA (UG) (haftungsbeschränkt) Compositions and methods thereof
JP7186777B2 (ja) * 2018-07-27 2022-12-09 中国塗料株式会社 防汚塗料組成物、防汚塗膜、防汚塗膜付き基材及びその製造方法、並びに補修方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126275A (ja) * 1983-12-13 1985-07-05 Otsuka Pharmaceut Co Ltd ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) 1984-07-19 1987-03-06 Roussel Uclaf Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
EP0189612B1 (fr) 1984-12-21 1992-11-04 Duphar International Research B.V Médicaments à activité psychotrope
EP0190472B1 (fr) 1984-12-21 1989-07-12 Duphar International Research B.V Médicaments à activité antipsychotique
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
JP3989554B2 (ja) * 1996-03-29 2007-10-10 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ ピペラジンおよびピペリジン化合物
TW530054B (en) * 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
GB9811879D0 (en) * 1998-06-03 1998-07-29 Knoll Ag Therapeutic agents
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US20030186838A1 (en) * 2000-05-12 2003-10-02 Feenstra Roelof W. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
EP1283838B1 (fr) * 2000-05-12 2003-12-03 Solvay Pharmaceuticals B.V. Composes de piperazine et piperidine

Also Published As

Publication number Publication date
HK1055952A1 (en) 2004-01-30
US7297699B2 (en) 2007-11-20
US6911448B2 (en) 2005-06-28
CZ20023721A3 (cs) 2003-02-12
HUP0302016A2 (hu) 2003-09-29
AR028443A1 (es) 2003-05-07
SK286778B6 (sk) 2009-05-07
US20060089366A1 (en) 2006-04-27
AU6392701A (en) 2001-11-20
CA2405971A1 (fr) 2001-11-15
JP2003532729A (ja) 2003-11-05
CN1429226A (zh) 2003-07-09
CN1174979C (zh) 2004-11-10
ES2211809T3 (es) 2004-07-16
UA72337C2 (uk) 2005-02-15
CA2405971C (fr) 2010-03-30
AU2001263927B2 (en) 2004-09-30
NZ522116A (en) 2004-04-30
DK1283838T3 (da) 2004-03-22
RU2261250C2 (ru) 2005-09-27
NO20025365D0 (no) 2002-11-08
DE60101386T2 (de) 2004-05-27
US20030119849A1 (en) 2003-06-26
SK15872002A3 (sk) 2003-04-01
CZ301464B6 (cs) 2010-03-10
DE60101386D1 (de) 2004-01-15
NO20025365L (no) 2002-11-08
EP1283838B1 (fr) 2003-12-03
IL152177A0 (en) 2003-05-29
EP1283838A1 (fr) 2003-02-19
NO323778B1 (no) 2007-07-02
WO2001085725A1 (fr) 2001-11-15
ZA200208537B (en) 2004-01-22
PL198857B1 (pl) 2008-07-31
BR0110592A (pt) 2003-04-01
PL358201A1 (en) 2004-08-09
MXPA02011084A (es) 2003-03-10
IL152177A (en) 2009-08-03
TR200302294T4 (tr) 2004-02-23
PT1283838E (pt) 2004-04-30
ATE255578T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
NO20023787D0 (no) Piperazin- og piperidinderivater
AR028343A1 (es) Derivados de pirrolidina y piperidina
DK1325008T3 (da) Piperazinderivater
ATE397595T1 (de) Piperazin-derivate
DZ3306A1 (fr) Derives de piperazine
DE60103472D1 (de) Rohrschneider
NO20026125L (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
DZ3370A1 (fr) Composes de piperazine et piperidine
ATE390099T1 (de) Zwischenwirbelkunststoffimplantat
DK1131308T3 (da) Piperazin- og piperidinderivater
ATE321042T1 (de) Piperazin-derivate
NO20023954L (no) Substituerte piperasinforbindelser
DE50113112D1 (de) Schaltungsanordnung
MA25651A1 (fr) Composes caldilytiques
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE50009171D1 (de) Co 2 - kompressor
DK1202966T3 (da) Piperidinalkoholer
FI4480U1 (fi) Hienonnuslaite
EP1305019A4 (fr) Composes immunomodulateurs
PT1131308E (pt) Novos compostos de piperazina e piperidina
DE50115426D1 (de) Schaltungsanordnung
FR2814381B1 (fr) Dechiqueteur
DK1037892T3 (da) Piperidinderivater
ATA9272000A (de) Revisionstür
SE0003095D0 (sv) Trash comersiale